Finance

Revenues increase 18.2% for infectious disease detection and monitoring company

Published in Hepatitis Weekly, September 23rd, 2002

Boston Biomedica, Inc., which provides products and services for the detection and monitoring of infectious diseases such as AIDS and viral hepatitis, announced that revenue from continuing operations for the 3 months ended June 30, 2002 was $5,856,096, an increase of $902,981 or 18.2%, compared with revenue from continuing operations of $4,953,115 for the 3 months ended March 31, 2002.

Loss from continuing operations for the 3 months ended June 30, 2002 declined to $(293,893), or $(0.04) per diluted share, compared with a loss from continuing operations of $(886,866), or $(0.14) per diluted share, for the 3 months ended March 31, 2002.

Revenue from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-09-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry